Karim Mikhail
Chief Executive Officer chez Amarin Pharma, Inc.
Fortune : 957 156 $ au 31/03/2024
Provenance du réseau au premier degré de Karim Mikhail
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Karim Mikhail via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HURON CONSULTING GROUP INC. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VALERITAS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Seton Hall University | College/University | Undergraduate Degree Masters Business Admin | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale New Haven Health Services Corp.
 Yale New Haven Health Services Corp. Miscellaneous Commercial ServicesCommercial Services Yale-New Haven Health Services Corp. operates as a non-profit organization that provides healthcare services. It offers geriatrics, oncology, neurology and neurosurgery, orthopedics, primary care, transplantation, clinical programs and services, health education, and research and clinical trials. The company was founded in 1995 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Pharmaceuticals: Generic | Director of Finance/CFO | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| Pharmacia GmbH | Private Equity Investor | ||
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Pharmaceuticals: Major | Corporate Secretary Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University Law Center | College/University | Graduate Degree Graduate Degree | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| INFLARX N.V. | Biotechnology | General Counsel Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Masters Business Admin | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VALERITAS INC | Medical Specialties | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 40 |
| Irlande | 3 |
| Canada | 3 |
| Allemagne | 3 |
| Israël | 2 |
Sectorielle
| Health Technology | 33 |
| Finance | 7 |
| Consumer Services | 7 |
| Commercial Services | 5 |
Opérationnelle
| Director/Board Member | 148 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 64 |
| Chairman | 35 |
| Undergraduate Degree | 25 |
Relations les plus connectées
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| David M. Stack | 27 |
| Per Wold-Olsen | 24 |
| Lars Ekman | 21 |
| Erin Enright | 19 |
| Keith Horn | 19 |
| Kristine Peterson | 18 |
| Jan van Heek | 15 |
| Alfonso Zulueta | 14 |
| Alan J. Wills | 13 |
| John Thero | 11 |
| Lisa M. DeFrancesco | 11 |
| Patrick O’Sullivan | 11 |
| David Keenan | 11 |
| Jason Marks | 11 |
- Bourse
- Insiders
- Karim Mikhail
- Connexions Sociétés
